A full listing of Novartis clinical trials which also includes active and completed studies can be found at ClinicalTrials.gov.
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. These studies ensure that an investigative medicine is effective and safe, and rely entirely on patients and healthy volunteers. Learn more about clinical trials at Novartis including opportunities to get involved.
Participating in a clinical trial
About clinical trials
A clinical trial is a research study that is done to find out if a treatment can improve people`s health. Learn more about clinical trials.
Information for patients
Deciding to take part in a clinical trial is an important decision. Learn more before deciding to enroll.
Video: Understanding clinical trials
Learn more about participating in clinical trials in this series of videos.
Inside the Four Phases of a Clinical Trial
We've partnered with CNN to explain the clinical trial process
Transparency
Our vision is to be a trusted leader in changing the practice of medicine. Novartis believes one aspect of building trust with society and research participants is through making our ongoing trials and their trial results public, regardless of the outcome of the trial.
Clinical trial results
Novartis has long been dedicated to informing the public about interventional trial results. Novartis launched the results website in 2005 becoming one of the first companies to provide this information to the public.
Trial summaries for patients
Trial summaries for patients are written in easier to understand language than the corresponding technical result summaries. Patients summaries are provided in English and local languages.
Clinical trials in numbers
Ethics and diversity
Ethics
For every Novartis clinical trial our primary responsibility is to protect the safety, well-being and legal rights of all participants and ensure adherence to the highest ethical standards for clinical research.
Diversity
Diversity in clinical trials is integral to who we are at Novartis and we are working hard to improve both the diversity of patients enrolled in our clinical research and the investigators involved in our trials.
Resources for healthcare professionals and researchers
Clinical trial data sharing
Novartis is committed to sharing with qualified external researchers, access to anonymized patient level data and clinical study reports from eligible studies.
Managed Access Programs
Managed Access makes investigational or unapproved treatments available to eligible patients with serious or life-threatening diseases.
Investigator Initiated Trials
As part of our commitment to delivering innovative therapies, Novartis believes in the need to support ethical independent clinical research conducted by qualified third-party investigators.
Country resources
COVID-19 clinical trials
Novartis is sponsoring and co-sponsoring a number of coronavirus (COVID-19) clinical trials and participating in multiple research collaborations
Latest clinical trials news
Novartis data at ASCO and EHA showcase latest oncology research and innovation, including in breast and prostate cancer
Novartis provides an update on Phase III ligelizumab (QGE031) studies in chronic spontaneous urticaria (CSU)
Novartis announces T-Charge™, next-generation CAR-T platform with first-in-human data at ASH 2021
Clinical trials stories
Building clinical trial diversity
Vas Narasimhan reflects on how to increase diversity in clinical trials
Turning the sound up on patient voices in lung cancer research and development
Global Oncology Patient Insights Panels (GOPIPs) are giving patients and advocates a critical voice in advancing lung cancer trials.
Podcast: Demystifying clinical trials
Lani Hashimoto and Rosemary Rebuli talk about the challenges of setting up clinical trials and the need to include a diverse patient population when testing new medicines.